1,4-Dibromobutane
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
110-52-1BrCCCCBrULTHEAFYOOPTTB-UHFFFAOYSA-Nstructure given in first source
110-52-1DTXSID5044364CHEMBL3185714Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H301 (76.8%): Toxic if swallowed [Danger Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P273, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 69 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Not Classified
Not Classified
Chemical: Butane, 1,4-dibromo-
Status: Active Update: 27-11-2019 https://echa.europa.eu/registration-dossier/-/registered-dossier/19884
1,4-Dibromobutane: Does not have an individual approval but may be used under an appropriate group standard
Verwenden1,4-Dibromobutane is used as an intermediate involved in the synthesis of active pharmaceutical ingredient and other organic compounds. It is also used in the investigation of metabolism of two halopropanes such as 1,3-dichloropropane and 2,2-dichloropropane. Further, it acts as a reagent to prepare diazadioxa oxovanadium(IV) macrocyclic complexes.